Description of Research Expertise:
Cancer immunotherapy
Vaccines
Cellular therapy
Phase I trials
Selected Publications:
Raje N, Faber E, Richardson P, Schiller G, Hohl R, Cohen AD, Forero A, Carpenter S, Nguyen T, Conti I, Kaiser C, Cronier D, Wooldridge J, Anderson K: Phase 1 study of tabalumab, a human anti-B-cell activating factor antibody, and bortezomib in patients with relapsed/refractory multiple myeloma Clinical Cancer Research 22 : 5688-5695,2016.
Adam D. Cohen, Alfred L. Garfall, Edward A Stadtmauer, Simon Francis Lacey, Eric Lancaster, Dan T. Vogl, Karen Dengel, David E Ambrose, Fang Chen, Gabriela Plesa, Irina Kulikovskaya, Vanessa E Gonzalez, Minnal Gupta, Regina M Young, Tenesia Carey, Regina Ferthio, Brendan M. Weiss, Celeste Richardson, Randi E. Isaacs, J. Joseph Melenhorst, Bruce L. Levine, Carl H June, Michael C. Milone: B-Cell Maturation Antigen (BCMA)-Specific Chimeric Antigen Receptor T Cells (CART-BCMA) for Multiple Myeloma (MM): Initial Safety and Efficacy from a Phase I Study Blood (ASH Annual Meeting) 128 : #1147,2016.
Muzaffar H. Qazilbash, Edward A Stadtmauer, Veera Baladandayuthapani, Heather Lin, Beryl M. Tross, Medhavi Honhar, Soung-Chul Cha, Kunhwa Kim, Sheetal S Rao, Michael Popescu, Nina Shah, Qaiser Bashir, Krina Patel, Elizabeth J. Shpall, Donna M. Weber, Sheeba K. Thomas, Jatin J. Shah, Robert Z. Orlowski, Naseem DS Kerr, Alfred L. Garfall, Adam D. Cohen, Karen Dengel, Carl H June, Richard E. Champlin, Larry Kwak: Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation Blood (ASH Annual Meeting) 128 : #4548,2016.
Lesokhin AM, Ansell SM, Armand P, Scott EC, Halwani A, Gutierrez M, Millenson MM, Cohen AD, Schuster SJ, Lebovic D, Dhodapkar M, Avigan D, Chapuy B, Ligon AH, Freeman GJ, Rodig SJ, Cattry D, Zhu L, Grosso JF, Shipp MA, Borello I, Timmerman J.: Safety, Pharmacokinetics, Immunoregulatory and Preliminary Antitumor Activity of Nivolumab in Patients with Relapsed or Refractory Hematologic Malignancy Journal of Clinical Oncology 34 : 2698-2704,2016.
Adam D. Cohen, Rakesh Popat, Suzanne Trudel, Paul G Richardson, Ed N. Libby III, Nikoletta Lendvai, Larry D. Anderson Jr., Heather J. Sutherland, Stephen DeWall, Catherine E Ellis, Zangdong He, Jolly Mazumdar, Catherine Wang, Joanna B. Opalinska, Peter M. Voorhees: First in Human Study with GSK2857916, an Antibody Drug Conjugated to Microtubule-Disrupting Agent Directed Against B-Cell Maturation Antigen (BCMA) in Patients with Relapsed/Refractory Multiple Myeloma (MM): Results from Study BMA117159 Part 1 Dose Escalation Blood (ASH Annual Meeting) 128 : #1148,2016.
Adam D. Cohen, Heather Landau, Emma C. Scott, Michaela Liedtke, Jonathan L. Kaufman, Michael Rosenzweig, Cristina Gasparetto, David H. Vesole, Vaishali Sanchorawala, Suzanne Lentzsch, Christina L. Gomes, Raymond L. Comenzo, Brian G.M. Durie: Safety and Efficacy of Carfilzomib (CFZ) in Previously-Treated Systemic Light-Chain (AL) Amyloidosis Blood (ASH Annual Meeting) 128 : #645,2016.
Brendan M. Weiss, Sigrun H Lund, Magnus Bjorkholm, Adam D. Cohen, Laura Dember, Ola Landgren, Sigurdur Y Kristinsson: Improved Survival in AL Amyloidosis: A Population-Based Study on 1,430 Patients Diagnosed in Sweden 1995-2013 Blood (ASH Annual Meeting) 128 : #4448,2016.
Alex Ganetsky, Noelle V Frey, Alison W Loren, Elizabeth O. Hexner, James K Mangan, Saar I Gill, Selina Luger, Adam D. Cohen, Daria V Babushok, Edward A Stadtmauer, Jacqueline Smith, William R. Drobyski, Sarah K Kraus, Colleen Timlin, David L. Porter: Tocilizumab Is Highly Active for Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Gastrointestinal Tract Blood (ASH Annual Meeting) 128 : #2245,2016.
Alfred L. Garfall, Eric Lancaster, Edward A Stadtmauer, Simon F. Lacey, Karen Dengel, David E Ambrose, Fang Chen, Minnal Gupta, Irina Kulikovskaya, Dan T. Vogl, Gabriela Plesa, Brendan M Weiss, Regina Ferthio, Celeste Richardson, Jan Joseph Melenhorst, Bruce L Levine, Carl H June, Michael Milone, Adam D. Cohen: Posterior Reversible Encephalopathy Syndrome (PRES) after Infusion of Anti-Bcma CAR T Cells (CART-BCMA) for Multiple Myeloma: Successful Treatment with Cyclophosphamide Blood (ASH Annual Meeting) 128 : #5702,2016.
Lilly Wilson, Adam D. Cohen, Brendan M. Weiss, Dan T. Vogl, Alfred L. Garfall, Donna L. Capozzi, Patricia Mangan, Mary Sanchez, Colleen Erb, Edward Stadtmauer: Pembrolizumab in Combination with Pomalidomide and Dexamethasone (PEMBRO/POM/DEX) for Pomalidomide Exposed Relapsed or Refractory Multiple Myeloma Blood (ASH Annual Meeting) 128 : #2119,2016.